{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:22:13Z","timestamp":1762431733384},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"S22","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T00:00:00Z","timestamp":1577664000000},"content-version":"vor","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Tumor purity plays an important role in understanding the pathogenic mechanism of tumors. The purity of tumor samples is highly sensitive to tumor heterogeneity. Due to Intratumoral heterogeneity of genetic and epigenetic data, it is suitable to study the purity of tumors. Among them, there are many purity estimation methods based on copy number variation, gene expression and other data, while few use DNA methylation data and often based on selected information sites. Consequently, how to choose methylation sites as information sites has an important influence on the purity estimation results. At present, the selection of information sites was often based on the differentially methylated sites that only consider the mean signal, without considering other possible signals and the strong correlation among adjacent sites.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Considering integrating multi-signals and strong correlation among adjacent sites, we propose an approach, PEIS, to estimate the purity of tumor samples by selecting informative differential methylation sites. Application to 12 publicly available tumor datasets, it is shown that PEIS provides accurate results in the estimation of tumor purity which has a high consistency with other existing methods. Also, through comparing the results of different information sites selection methods in the evaluation of tumor purity, it shows the PEIS is superior to other methods.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>A new method to estimate the purity of tumor samples is proposed. This approach integrates multi-signals of the CpG sites and the correlation between the sites. Experimental analysis shows that this method is in good agreement with other existing methods for estimating tumor purity.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12859-019-3227-1","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T08:02:27Z","timestamp":1577692947000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["PEIS: a novel approach of tumor purity estimation by identifying information sites through integrating signal based on DNA methylation data"],"prefix":"10.1186","volume":"20","author":[{"given":"Shudong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanchen","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinzeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,30]]},"reference":[{"key":"3227_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s13059-014-0419-x","volume":"15","author":"X Zheng","year":"2014","unstructured":"Zheng X, Qian Z, Wu HJ, Wei L. MethylPurify: tumor purity deconvolution and differential methylation detection from single tumor DNA methylomes. Genome Biol. 2014;15:419.","journal-title":"Genome Biol"},{"key":"3227_CR2","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/bioinformatics\/bty011","volume":"34","author":"M Benelli","year":"2018","unstructured":"Benelli M, Romagnoli D, Demichelis F. Tumor purity quantification by clonal DNA methylation signatures. Bioinformatics. 2018;34:1642\u20139.","journal-title":"Bioinformatics"},{"key":"3227_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/bfgp\/elw016","volume":"15","author":"F Wang","year":"2016","unstructured":"Wang F, Zhang N, Wang J, Wu H, Zheng X. Tumor purity and differential methylation in cancer epigenomics. Brief Funct Genom. 2016;15:elw016.","journal-title":"Brief Funct Genom"},{"key":"3227_CR4","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1093\/bioinformatics\/btv370","volume":"31","author":"N Zhang","year":"2015","unstructured":"Zhang N, Wu H-J, Zhang W, Wang J, Wu H, Zheng X. Predicting tumor purity from methylation microarray data. Bioinformatics. 2015;31:3401.","journal-title":"Bioinformatics"},{"key":"3227_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13059-016-1143-5","volume":"18","author":"X Zheng","year":"2017","unstructured":"Zheng X, Zhang N, Wu HJ, Wu H. Estimating and accounting for tumor purity in the analysis of DNA methylation data from cancer studies. Genome Biol. 2017;18:17.","journal-title":"Genome Biol"},{"key":"3227_CR6","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, Trevino V, Shen H, Laird PW, Levine DA. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"3227_CR7","doi-asserted-by":"publisher","first-page":"16910","DOI":"10.1073\/pnas.1009843107","volume":"107","author":"PV Loo","year":"2010","unstructured":"Loo PV, Nordgard SH, Lingj\u00e6rde OC, Russnes HG, Rye IH, Sun W, Weigman VJ, Marynen P, Zetterberg A, Naume B. Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A. 2010;107:16910\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3227_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T, Laird PW, Onofrio RC, Winckler W, Weir BA. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol. 2012;30:413\u201321.","journal-title":"Nat Biotechnol"},{"key":"3227_CR9","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/ng.865","volume":"43","author":"KD Hansen","year":"2011","unstructured":"Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, Wen B, Wu H, Liu Y, Diep D, et al. Increased methylation variation in epigenetic domains across cancer types. Nat Genet. 2011;43:768\u201375.","journal-title":"Nat Genet"},{"key":"3227_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature08514","volume":"462","author":"R Lister","year":"2009","unstructured":"Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009;462:315\u201322.","journal-title":"Nature"},{"key":"3227_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1172\/JCI9462","volume":"105","author":"B Tycko","year":"2000","unstructured":"Tycko B. Epigenetic gene silencing in cancer. J Clin Invest. 2000;105:401\u20137.","journal-title":"J Clin Invest"},{"key":"3227_CR12","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/gb-2014-15-2-r31","volume":"15","author":"AE Jaffe","year":"2014","unstructured":"Jaffe AE, Irizarry RA. Accounting for cellular heterogeneity is critical in epigenome-wide association studies. Genome Biol. 2014;15:R31.","journal-title":"Genome Biol"},{"key":"3227_CR13","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/bioinformatics\/bts013","volume":"28","author":"D Wang","year":"2012","unstructured":"Wang D, Yan L, Hu Q, Sucheston LE, Higgins MJ, Ambrosone CB, Johnson CS, Smiraglia DJ, Liu S. IMA: an R package for high-throughput analysis of Illumina\u2019s 450K Infinium methylation data. Bioinformatics. 2012;28:729\u201330.","journal-title":"Bioinformatics"},{"key":"3227_CR14","doi-asserted-by":"publisher","first-page":"e74275","DOI":"10.1371\/journal.pone.0074275","volume":"8","author":"D Wu","year":"2013","unstructured":"Wu D, Gu J, Zhang MQ. FastDMA: an Infinium HumanMethylation450 Beadchip analyzer. PLoS One. 2013;8:e74275.","journal-title":"PLoS One"},{"key":"3227_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/bib\/bbs038","volume":"14","author":"RM Kuhn","year":"2013","unstructured":"Kuhn RM, Haussler D, James Kent W. The UCSC genome browser and associated tools. Brief Bioinform. 2013;14:144\u201361.","journal-title":"Brief Bioinform"},{"key":"3227_CR16","doi-asserted-by":"publisher","first-page":"8971","DOI":"10.1038\/ncomms9971","volume":"6","author":"D Aran","year":"2015","unstructured":"Aran D, Sirota M, Butte AJ. Systematic pan-cancer analysis of tumour purity. Nat Commun. 2015;6:8971.","journal-title":"Nat Commun"},{"key":"3227_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1677\/erc.1.01184","volume":"13","author":"AS Perry","year":"2006","unstructured":"Perry AS, Foley R, Woodson K, Lawler M. The emerging roles of DNA methylation in the clinical management of prostate cancer. Endocr Relat Cancer. 2006;13:357.","journal-title":"Endocr Relat Cancer"},{"key":"3227_CR18","doi-asserted-by":"publisher","first-page":"e62950","DOI":"10.1371\/journal.pone.0062950","volume":"8","author":"T Gao","year":"2013","unstructured":"Gao T, He B, Pan Y, Li R, Xu Y, Chen L, Nie Z, Gu L, Wang SJPO. The association of retinoic acid receptor beta2(RAR\u03b22) methylation status and prostate cancer risk: a systematic review and meta-analysis. PLoS One. 2013;8:e62950.","journal-title":"PLoS One"},{"key":"3227_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2217\/epi.13.58","volume":"5","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Zhang J, Shang J. Quantitative identification of differentially methylated loci based on relative entropy for matched case\u2013control data. Epigenomics. 2013;5:631\u201343.","journal-title":"Epigenomics"},{"key":"3227_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/bib\/bbx097","volume":"20","author":"Y Wang","year":"2017","unstructured":"Wang Y, Teschendorff AE, Widschwendter M, Wang S. Accounting for differential variability in detecting differentially methylated regions. Brief Bioinform. 2017;20:47\u201357.","journal-title":"Brief Bioinform"},{"key":"3227_CR21","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/ng1909","volume":"38","author":"F Eckhardt","year":"2006","unstructured":"Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, Burton J, Cox TV, Davies R. Down TAJNG: DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet. 2006;38:1378\u201385.","journal-title":"Nat Genet"},{"key":"3227_CR22","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1093\/bioinformatics\/btt498","volume":"29","author":"T Sofer","year":"2013","unstructured":"Sofer T, Schifano ED, Hoppin JA, Hou L, Baccarelli AA. A-clustering: a novel method for the detection of co-regulated methylation regions, and regions associated with exposure. Bioinformatics. 2013;29:2884\u201391.","journal-title":"Bioinformatics"},{"key":"3227_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gendis.2018.02.003","volume":"5","author":"Y Qin","year":"2018","unstructured":"Qin Y, Hao F, Ming C, Hao W, XJG Z. Diseases: infiniumPurify: an R package for estimating and accounting for tumor purity in cancer methylation research. Genes Dis. 2018;5:43\u20135.","journal-title":"Genes Dis"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-019-3227-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-019-3227-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-019-3227-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T00:08:28Z","timestamp":1609200508000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-019-3227-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":23,"journal-issue":{"issue":"S22","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3227"],"URL":"https:\/\/doi.org\/10.1186\/s12859-019-3227-1","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"30 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"714"}}